SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending amidst strong community anticipation for imminent Phase 3 REGAL trial results for its lead AML drug, GPS, following recent CEO statements hinting at curative outcomes. This confluence of factors is fueling discussions of significant institutional interest, a potential short squeeze, and major buyout prospects from pharmaceutical giants.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid escalating global tensions, which underscore the strategic importance of its heavy rare earth project in Greenland for Western defense and supply chain independence. The community is highly bullish, anticipating a forthcoming Bankable Feasibility Study update to reveal a significantly higher valuation for the Tanbreez asset, challenging current market pricing.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company (TMC) is trending following the National Oceanic and Atmospheric Administration's determination that its consolidated deep-seabed mining application is in "substantial compliance," signaling a critical de-risking milestone in the U.S. regulatory process. The community is actively discussing this as a major step towards commercial recovery, anticipating significant upside given the broader context of U.S. efforts to secure critical mineral independence.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is trending due to a massive price surge and extraordinary trading volume, driven by news of a $40 million private placement financing. The community is actively discussing the potential for a short squeeze and rapid upside momentum, while others express caution regarding the low private placement price and the stock's speculative volatility.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

Relmada Therapeutics is experiencing a significant surge in volume and price following positive Phase 2 interim data for its bladder cancer treatment NDV-01, which boasts high response rates, and a substantial private placement financing. The community is debating whether this marks a sustained momentum play or if past setbacks and potential dilution still warrant caution despite the bullish news.

Aureus Greenway Holdings, Inc. engages in the ownership and operation of public golf country clubs, namely Kissimmee Bay Country Club and Remington Golf Club. It operates through the following segments: Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental, Membership Dues, Food and Beverage Services, and Ancillary Services and Amenities. The Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental segment is involved in the collection of fees for every round of eighteen holes, provision of driving ranges for practice, sale of golf apparel and equipment, and rental of golf products and cars. The Membership Dues segment refers to the membership fees for customers to access the club's facilities and services for a set period or daily at the point of sale. The Food and Beverage Services segment provides culinary services such as catering. The Ancillary Services and Amenities segment offers leisure activities hosted in an on-premises clubhouse, kitchen, bar, and dining area. The company was founded on December 22, 2023 and is headquartered in Kissimmee, FL.

Aureus Greenway Holdings Inc.

Aureus Greenway Holdings (AGH) is surging following news of its merger with Powerus, a drone manufacturer backed by Eric and Donald Trump Jr., transforming it into a U.S. defense-drone company. The community is sharply divided, with bulls anticipating significant government contracts and a potential short squeeze, while skeptics point to concerns over dilution and alleged insider trading.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is drawing attention after reporting strong Q1 results, including a significant surge in networking revenue and raised full-year guidance, fueled by robust AI demand and the recently completed Juniper acquisition. The community is actively discussing its potential for a re-rating as a key full-stack AI infrastructure and networking provider.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending due to a significant downtrend and intense community debate over whether it represents a "value trap" or a "generational buying opportunity." Upcoming earnings and a Supreme Court decision on tariffs are key catalysts, with investors closely watching if the company's $300 million restructuring and "Win Now" strategy can reverse recent losses and rising competition.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending as a competitor's oral SERD drug failure in late-stage breast cancer trials pivots market attention to OLMA's palazestrant as a potentially best-in-class asset. This shift, along with strong analyst backing and high institutional ownership, is fueling community speculation regarding its acquisition potential and future market leadership despite a recent share offering.

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals is currently trending due to overwhelmingly positive Phase 3 trial results for its epilepsy treatment, azetukalner, which significantly exceeded expectations and is seen by the community as a potentially differentiated and best-in-class drug. While the strong data has driven a substantial surge, a subsequent public offering of common shares is also a major discussion point, with investors weighing its long-term funding benefits against near-term dilution concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royce & Associates LP Decreases Position in Forrester Research, Inc. $FORR

Royce & Associates LP cut its holdings in Forrester Research, Inc. (NASDAQ:FORR - Free Report) by 90.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Costco takes big step to fix one of members' biggest complaints

As a 20-year Costco member, there are clearly many things I love about the store. If I didn't, I wouldn't keep paying a membership fee year after year.Some of my favorite Costco membership perks are...

Forrester Announces The Agenda For Its 2026 CX Events To Help Address The Challenges AI Cant Handle Alone

Forrester (Nasdaq: FORR) today announced the agenda for its global customer experience (CX) event series: CX Summit EMEA, being held in Amsterdam, June 810, 2026; CX Forum East, being held in New...

Forrester Research Sees Unusually High Options Volume (NASDAQ:FORR)

Forrester Research, Inc. (NASDAQ:FORR - Get Free Report) was the recipient of unusually large options trading activity on Monday. Traders acquired 7,000 put options on the stock. This represents an...

Walmart Issues Cautious Outlook  Open Interest 2/19/2026

Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Walmart waving a warning flag the world's largest retailer citing trade and labor concerns...

Grammy-Nominated Rock Band The Fray To Headline Forresters 2026 B2B Summit North America

Forrester (Nasdaq: FORR) today announced that rock band The Fray will be this years headline performer at Forresters B2B Summit North America, taking place in Phoenix, April 2629, 2026. This years...

Forrester Research (NASDAQ:FORR) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Forrester Research from a "buy" rating to a "hold" rating in a report on Sunday...

Forrester Research Q4 Earnings Call Highlights

Forrester Research (NASDAQ:FORR) executives said the company is leaning further into artificial intelligence as both a product opportunity and a differentiator for its research franchise, even as it...

Here's What Key Metrics Tell Us About Forrester Research (FORR) Q4 Earnings

The headline numbers for Forrester Research (FORR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Forrester Research (NASDAQ:FORR) Releases FY 2026 Earnings Guidance

Forrester Research (NASDAQ:FORR) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.720-0.820 for the period, compared to the consensus estimate of 1.120. The company also...

Forrester Research, Inc. engages in the provision of advisory services. It operates through the following business segments: Research, Consulting, and Events. The Research segment includes the revenues of the research, connect, and analytics products. The Consulting segment consists of project consulting organization. The Events segment refers to developing and hosting in-person and virtual events. The firm serves the business-to-business marketing, sales, information technology, business-to-consumer marketing, and customer experience sectors. The company was founded by George F. Colony on July 7, 1983 and is headquartered in Cambridge, MA.

Current Price	$6.30
Prev Close	$6.46
Open	$6.41
Dividend Yield	0.00%
50-Day Moving Average	$7.19
Beta	0.67
Avg. Volume	209,234.14
PE Ratio	-1.02

52-Week High	$11.57
52-Week Low	$4.91
Market Capitalization	$154.18M
EPS (Annual)	-$6.28
Price to Book	0.78
Revenue Per Employee	$252,633.99

FORR
Forrester Research Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FORR News

FORRForrester Research Inc.